title: Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy.
abstract: Angiogenesis is a crucial process in tumor pathogenesis as it sustains malignant cells with nutrients and oxygen. It is well known that tumor cells secrete various growth factors, including VEGF, which triggers endothelial cells to form new capillaries. Prevention of expansion of new blood vessel networks results in reduced tumor size and metastasis. Production of VEGF is driven by hypoxia via transcriptional activation of the VEGF gene by HIF-1α.Tumours are now understood to contain different types of cells, and it is the cancer stem cells that retain the ability to drive the tumour's growth. They are called cancer stem cells because, like stem cells present in normal tissues of the body, they can self-renew and differentiate. These cancer stem cells are responsible for the relapse of cancer as they are found to be resistant to conventional modes of cancer therapy like chemotherapy and radiation.In this review, a novel mode of treatment of cancer is proposed, which utilizes the twin nanoparticle to target endothelial cells in the niche of cancer stem cell. The nanoparticle discussed in this review, is a twin nanoparticle of iron coated with gold, which targets VEGF positive cell in the vicinity of cancer stem cell. In the twin nanoparticle, one particle will recognize cancer stem cell, and another conjugated nanoparticle will recognize VEGF positive cells, thereby inhibiting endothelial cells in the proximity of cancer stem cell. This novel strategy will inhibit angiogenesis near cancer stem cell hence new tumour cannot grow and old tumour will be unable to metastasize.
authors.affiliation: Functional Genomics and Cancer biology lab, CME, VIT University, Vellore, India. ambasta@vit.ac.in.
authors.forename: Rashmi K
authors.initials: RK
authors.lastname: Ambasta
authors.forename: Archita
authors.initials: A
authors.lastname: Sharma
authors.forename: Pravir
authors.initials: P
authors.lastname: Kumar
references.citation: Cancer Biol Ther. 2007 May;6(5):763-8
references.pmid: 17592251
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references.pmid: 12629218
references.citation: Cancer Res. 2003 Nov 1;63(21):7301-9
references.pmid: 14612527
references.citation: J Immunol. 2005 Jan 1;174(1):215-22
references.pmid: 15611243
references.citation: Hum Pathol. 2008 Nov;39(11):1597-605
references.pmid: 18656241
references.citation: Matrix Biol. 2008 Sep;27(7):589-99
references.pmid: 18640270
references.citation: Dalton Trans. 2009 Aug 7;(29):5583-91
references.pmid: 20449070
references.citation: Mol Cancer Ther. 2009 Jul;8(7):1761-71
references.pmid: 19567820
references.citation: J Clin Oncol. 2010 Feb 10;28(5):780-7
references.pmid: 20048182
references.citation: Curr Med Chem. 2009;16(4):394-416
references.pmid: 19199913
references.citation: Biochem Pharmacol. 2011 May 15;81(10):1183-91
references.pmid: 21382350
references.citation: Biochem Biophys Res Commun. 2007 Dec 28;364(4):778-82
references.pmid: 17964286
references.citation: Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63
references.pmid: 17548814
references.citation: J Clin Oncol. 2010 Feb 20;28(6):1061-8
references.pmid: 20100962
references.citation: Lancet. 2007 Dec 22;370(9605):2103-11
references.pmid: 18156031
references.citation: N Engl J Med. 2004 Jun 3;350(23):2335-42
references.pmid: 15175435
references.citation: Lancet Oncol. 2010 Jul;11(7):619-26
references.pmid: 20570559
references.citation: Cancer Chemother Pharmacol. 2007 Jul;60(2):151-70
references.pmid: 17370072
references.citation: Eur J Cancer. 2005 May;41(8):1109-16
references.pmid: 15911233
references.citation: Trends Immunol. 2004 Jul;25(7):387-95
references.pmid: 15207507
references.citation: Drug Discov Today. 2010 Oct;15(19-20):842-50
references.pmid: 20727417
references.citation: J Exp Med. 1993 Dec 1;178(6):2077-88
references.pmid: 8245783
references.citation: J Phys Chem C Nanomater Interfaces. 2010 Jan 1;114(45):19194-19201
references.pmid: 21103390
references.citation: Cancer Res. 2003 Sep 15;63(18):5821-8
references.pmid: 14522905
references.citation: Am J Pathol. 2007 Dec;171(6):2033-9
references.pmid: 17991717
references.citation: Cancer Res. 2004 Jul 15;64(14):4931-41
references.pmid: 15256466
references.citation: Gastroenterology. 2007 Jun;132(7):2542-56
references.pmid: 17570225
references.citation: Angew Chem Int Ed Engl. 2008;47(1):173-6
references.pmid: 17992677
references.citation: World J Urol. 1996;14(3):166-74
references.pmid: 8806195
references.citation: Eur J Cancer. 2006 Dec;42(18):3127-39
references.pmid: 17098419
references.citation: Int J Nanomedicine. 2008;3(2):169-80
references.pmid: 18686777
references.citation: Nat Cell Biol. 2002 Jan;4(1):E2-5
references.pmid: 11780131
references.citation: World J Gastroenterol. 2009 May 14;15(18):2258-64
references.pmid: 19437567
references.citation: Cell Stem Cell. 2007 Sep 13;1(3):313-23
references.pmid: 18371365
references.citation: Best Pract Res Clin Haematol. 2009 Mar;22(1):115-28
references.pmid: 19285278
references.citation: Sci STKE. 2001 Dec 11;2001(112):re21
references.pmid: 11741095
references.citation: J Microencapsul. 2010;27(1):57-66
references.pmid: 19545221
references.citation: BMC Cancer. 2008 Feb 08;8:48
references.pmid: 18261235
references.citation: J Clin Oncol. 2007 Jun 10;25(17):2369-76
references.pmid: 17557949
references.citation: Oncologist. 2001;6 Suppl 5:32-9
references.pmid: 11700390
references.citation: Cancer Res. 2006 Oct 1;66(19):9339-44
references.pmid: 16990346
references.citation: Exp Cell Res. 2003 May 1;285(2):286-98
references.pmid: 12706123
references.citation: Mol Aspects Med. 2011 Apr;32(2):88-111
references.pmid: 21565214
references.citation: Nat Rev Cancer. 2005 Mar;5(3):161-71
references.pmid: 15738981
references.citation: Nature. 2001 Nov 1;414(6859):105-11
references.pmid: 11689955
references.citation: Biochem Biophys Res Commun. 2009 Mar 6;380(2):243-8
references.pmid: 19167346
references.citation: Cancer Res. 2011 Feb 1;71(3):634-9
references.pmid: 21266356
references.citation: Biochim Biophys Acta. 2010 Dec;1806(2):131-7
references.pmid: 20685298
references.citation: Mol Cancer. 2006 Dec 02;5:67
references.pmid: 17140455
references.citation: Nature. 2006 Jan 5;439(7072):84-8
references.pmid: 16397499
references.citation: BioDrugs. 2009;23(5):289-304
references.pmid: 19754219
references.citation: Adv Mater. 2009;21(30):3045-3052
references.pmid: 20011128
references.citation: N Engl J Med. 2007 Jan 11;356(2):125-34
references.pmid: 17215530
references.citation: J Nanosci Nanotechnol. 2010 Sep;10(9):5527-39
references.pmid: 21133071
references.citation: Pathology. 2010 Feb;42(2):105-12
references.pmid: 20085510
references.citation: Cancer Metastasis Rev. 1998 Jun;17(2):155-61
references.pmid: 9770111
references.citation: Cancer Res. 2007 Feb 1;67(3):1030-7
references.pmid: 17283135
references.citation: Neoplasia. 2005 Nov;7(11):967-76
references.pmid: 16331882
references.citation: Front Biosci. 2005 May 01;10:1415-39
references.pmid: 15769635
references.citation: Cancer Res. 2006 May 1;66(9):4553-7
references.pmid: 16651403
references.citation: Cancer Detect Prev. 2003;27(3):229-38
references.pmid: 12787731
references.citation: Breast Cancer Res. 2007;9(3):303
references.pmid: 17540049
references.citation: Br J Cancer. 2010 Mar 2;102(5):789-95
references.pmid: 20104230
references.citation: J Clin Oncol. 2009 Aug 1;27(22):3584-90
references.pmid: 19487381
references.citation: Biol Chem. 2008 Jul;389(7):799-811
references.pmid: 18627316
references.citation: Exp Cell Res. 2006 Mar 10;312(5):549-60
references.pmid: 16336962
references.citation: Cancer Cell. 2008 Feb;13(2):153-66
references.pmid: 18242515